Literature DB >> 17308316

Long-term molecular efficacy and safety of imatinib in a patient with chronic myeloid leukaemia after renal transplantation.

Antoine Thierry, Brigitte Dreyfus, Frank Bridoux, Ramzi Abou Ayache, Serge Milin, François Guilhot, Guy Touchard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17308316     DOI： 10.1093/ndt/gfm052

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  2 in total

1.  Clinical lessons to be learned from patients developing chronic myeloid leukemia while on immunosuppressive therapy after solid organ transplantation: yet another case after orthotopic heart transplantation.

Authors:  Christian Oberender; Lorenz Kleeberg; Nicola Nienhues; Martin Gresse; Bernd Dörken; Hanno Riess; Philipp le Coutre
Journal:  Case Rep Hematol       Date:  2014-11-16

2.  Computational Prediction of Biomarkers, Pathways, and New Target Drugs in the Pathogenesis of Immune-Based Diseases Regarding Kidney Transplantation Rejection.

Authors:  Rafael Alfaro; Helios Martínez-Banaclocha; Santiago Llorente; Victor Jimenez-Coll; José Antonio Galián; Carmen Botella; María Rosa Moya-Quiles; Antonio Parrado; Manuel Muro-Perez; Alfredo Minguela; Isabel Legaz; Manuel Muro
Journal:  Front Immunol       Date:  2021-12-15       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.